BMC Cancer

Get credit for your data

Are you holding on to data that you've not yet published? You can get recognition for it by publishing a data note in BMC Research Notes.

Garza et al_CC

Many cancer patients experience swelling of the limbs (lymphedema) following treatment of certain types of cancer, such as breast cancer. In this comprehensive Review, Stephen Povoski and colleagues discuss the surgical strategies that can be used to manage this debilitating and incurable condition.

Featured video: Microparticles, breast cancer's secret weapon?

Read the article

Aims and scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Editor

Alexandros Houssein, BioMed Central

Consulting Editors

Yanis Boumber, Fox Chase Cancer Center
Ken Herrmann, Universitätsklinikum Essen
Manami Inoue, University of Tokyo
Alan Lefor, Jichi Medical University
Christophe Nicot, Kansas University Medical Center
Stephen Povoski, The Ohio State University
Dirk Vordermark, Martin Luther University Halle-Wittenberg

Ken Herrmann, Consulting Editor

Prof. Dr. Ken Herrmann is a faculty member for the Department of Molecular and Medical Pharmacology of the University of California, Los Angeles (UCLA) and Chair of Nuclear Medicine at Universitätsklinikum Essen, Germany. Dr. Herrmann serves as Consulting Editor for BMC Cancer since 2017.

Meet our Consulting Editors

BMC Series blog

View feed

Predicting a soldier’s potential for developing depression and PTSD

Published on: 18 October 2017
11th International Conference on Behavior, Physiology and Genetics of Wildlife

Published on: 13 October 2017
A hazardous undertaking: how ant queens prevent disease during colony foundation

Published on: 13 October 2017

BMC Cancer

Get credit for your data

Featured review: Surgical management of cancer-related lymphedema

Featured video: Microparticles, breast cancer's secret weapon?

Articles

Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review

Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer

Isolation and characterization of three new anti-proliferative Sesquiterpenes from Polygonum barbatum and their mechanism via apoptotic pathway

¹⁸F- FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer

Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression

Time trends in municipal distribution patterns of cancer mortality in Spain

Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: Increased expression of a CD44 variant isoform after chemotherapy

E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition

Expression and role of oncogenic miRNA-224 in esophageal squamous cell carcinoma

Aims and scope

Editor

Consulting Editors

Ken Herrmann, Consulting Editor

BMC Series blog

Predicting a soldier’s potential for developing depression and PTSD

11th International Conference on Behavior, Physiology and Genetics of Wildlife

A hazardous undertaking: how ant queens prevent disease during colony foundation

Tweets

Follow

BMC Cancer

Contact us